Technical problem

Blinding and sham control in VR trials

A participant inside a headset knows whether the experience is therapeutic, so convincing placebo conditions and masking are hard to build. Trials often settle for blinding only the analysts, which leaves room for expectation effects.

StageClinical validation

Addressed by

Nothing in the catalog addresses this yet

This is a real gap rather than a missing page. If you know work that addresses it, suggest a record.

Provenance

Where this problem statement comes from

JMIR Mental Health — Recommendations for methodology of VR clinical trialsInternational working group recommends blinding analysts at minimum and checking perceived group assignment, acknowledging blinding is hard in VR. The problem statement is AVRMD's framing; the cited work documents the difficulty.